Skip to main content
Formula Using Routine Biochemical Markers Proved Superior to Forn's and APRI in Predicting Early vs. Late-Stage Liver Disease in the HIV/HCV Co-Infected Host
Department of Medicine
  • Margaret Hoffman-Terry, MD, FACP, Lehigh Valley Health Network
  • Joseph L Yozviak, DO, FACP, Lehigh Valley Health Network
  • J Mannino, Lehigh Valley Health Network
  • Sharon R Kimmel, PhD, MHA, Lehigh Valley Health Network
Publication/Presentation Date
Document Type
Citation Information

Hoffman-Terry, M., Yozviak, J., Mannino, J., & Kimmel, S. (2007, July 22-25). Formula using routine biochemical markers proved superior to forn's APRI in predicting early vs. late-staged liver disease in the HIV/HCV co-infected host. Poster presented at: The 4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Sydney, Australia.